[耐火性慢性咳的治疗:现状和前景]
L Zhang1, Aierken Alimire1, M R Zhang2
1Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
概括
耐火性慢性咳 (RCC) 难以治疗,通常与咳过敏有关. 目前的治疗方法提供了适度的益处,突出了需要新疗法和非药物治疗方法,以改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐火性慢性咳 (RCC) 带来了重大的临床挑战,影响了生活质量和心理健康.
- 咳过敏是许多RCC患者的公认,可治疗的特征.
- 目前的抗咳疗法表现出适度的疗效,可用的选择有限.
研究的目的:
- 审查目前耐火性慢性咳的治疗环境.
- 探索新兴的治疗策略和RCC管理的未来研究方向.
主要方法:
- 对RCC的药理和非药理干预措施的综合文献综述.
- 对当前治疗指南和临床试验数据的分析.
- 综合发现,以确定差距和未来的研究重点.
主要成果:
- 神经调节剂 (例如, gabapentin) 和新型受体对抗剂/激动剂 (例如,P2X3对抗剂) 是主要的药理疗法.
- 尽管取得了进展,但当前抗咳药物的疗效仍然温和.
- 对RCC的非药物治疗方法处于开发和应用的早期阶段.
结论:
- 耐火性慢性咳的有效管理需要解决潜在的咳过敏症.
- 对新型抗咳剂和非药物干预措施的进一步研究至关重要.
- 结合药理和非药理策略的多方面的方法可以改善RCC患者的治疗结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
324
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
324
COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Acute Respiratory Failure-V
214
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
214


